Neuroimmunology plays an important role in the development of pharmaceutical therapies for various neurological disorders. It constitutes of two complex systems of the body i.e. nervous system and immune system, malfunctioning of either or both can lead to various stress situations. Endocrine and nervous system combines to carry out various physiological activities and their interaction with each other is studied under Neuroendocrinology.
The global G protein, coupled receptors (GPCR) targeting drug market sharply fell in the last three years due to a series of patent expirations of blockbuster products. The market receded from nearly $111 billion to almost $100 billion with a -3.4% compound annual growth rate (CAGR) between 2010 and 2013. With the introduction of novel pharmacecuticals and newly appearing classes of drugs, Research expects this market to reach $114 billion by 2018, a CAGR of 2.7% from 2013 to 2018.